374 related articles for article (PubMed ID: 8959341)
21. Regulation of germ-line epsilon transcription and induction of epsilon switching in cloned EBV-transformed and malignant human B cell lines by cytokines and CD4+ T cells.
Gauchat JF; Gascan H; de Waal Malefyt R; de Vries JE
J Immunol; 1992 Apr; 148(7):2291-9. PubMed ID: 1347554
[TBL] [Abstract][Full Text] [Related]
22. Latent membrane protein 1 of Epstein-Barr virus plays an important role in the serum starvation resistance of Epstein-Barr virus-immortalized B lymphocytes.
Park CH; Kim HR; Kim J; Jang SH; Lee KY; Chung GH; Jang YS
J Cell Biochem; 2004 Mar; 91(4):777-85. PubMed ID: 14991769
[TBL] [Abstract][Full Text] [Related]
23. Different Epstein-Barr virus-B cell interactions in phenotypically distinct clones of a Burkitt's lymphoma cell line.
Gregory CD; Rowe M; Rickinson AB
J Gen Virol; 1990 Jul; 71 ( Pt 7)():1481-95. PubMed ID: 2165133
[TBL] [Abstract][Full Text] [Related]
24. Influence of Epstein-Barr virus latent gene expression on the apoptosis-inducing effects of cortisone and 2-chlorodeoxyadenosine (2-CDA) in B-cell lines.
Röth A; Pfaff P; Lange W; Finke J
Cytokines Mol Ther; 1996 Mar; 2(1):21-8. PubMed ID: 9384686
[TBL] [Abstract][Full Text] [Related]
25. Expression of interleukin 10 in B lymphocytes of different origin.
Finke J; Ternes P; Lange W; Mertelsmann R; Dölken G
Leukemia; 1993 Nov; 7(11):1852-7. PubMed ID: 7694007
[TBL] [Abstract][Full Text] [Related]
26. Epstein-Barr virus-transformed human precursor B cell lines: altered growth phenotype of lines with germ-line or rearranged but nonexpressed heavy chain genes.
Gregory CD; Kirchgens C; Edwards CF; Young LS; Rowe M; Forster A; Rabbitts TH; Rickinson AB
Eur J Immunol; 1987 Aug; 17(8):1199-207. PubMed ID: 3040424
[TBL] [Abstract][Full Text] [Related]
27. CDK9/CYCLIN T1 expression during normal lymphoid differentiation and malignant transformation.
Bellan C; De Falco G; Lazzi S; Micheli P; Vicidomini S; Schürfeld K; Amato T; Palumbo A; Bagella L; Sabattini E; Bartolommei S; Hummel M; Pileri S; Tosi P; Leoncini L; Giordano A
J Pathol; 2004 Aug; 203(4):946-52. PubMed ID: 15258998
[TBL] [Abstract][Full Text] [Related]
28. T cell leukemia I oncogene expression depends on the presence of Epstein-Barr virus in the virus-carrying Burkitt lymphoma lines.
Kiss C; Nishikawa J; Takada K; Trivedi P; Klein G; Szekely L
Proc Natl Acad Sci U S A; 2003 Apr; 100(8):4813-8. PubMed ID: 12672960
[TBL] [Abstract][Full Text] [Related]
29. Cell phenotype dependent expression of MHC class I antigens in Burkitt's lymphoma cell lines.
Masucci MG; Klein E
Semin Cancer Biol; 1991 Feb; 2(1):63-71. PubMed ID: 1655115
[TBL] [Abstract][Full Text] [Related]
30. Restoration of the LFA-3 adhesion pathway in Burkitt's lymphoma cells using an LFA-3 recombinant vaccinia virus: consequences for T cell recognition.
Griffin H; Rowe M; Murray R; Brooks J; Rickinson A
Eur J Immunol; 1992 Jul; 22(7):1741-8. PubMed ID: 1378014
[TBL] [Abstract][Full Text] [Related]
31. The LCR of EBV makes Burkitt's lymphoma endemic.
Niller HH; Salamon D; Banati F; Schwarzmann F; Wolf H; Minarovits J
Trends Microbiol; 2004 Nov; 12(11):495-9. PubMed ID: 15488390
[TBL] [Abstract][Full Text] [Related]
32. Expression of Egr-1 correlates with the transformed phenotype and the type of viral latency in EBV genome positive lymphoid cell lines.
Calogero A; Cuomo L; D'Onofrio M; de Grazia U; Spinsanti P; Mercola D; Faggioni A; Frati L; Adamson ED; Ragona G
Oncogene; 1996 Nov; 13(10):2105-12. PubMed ID: 8950977
[TBL] [Abstract][Full Text] [Related]
33. Expression of P2 receptors in human B cells and Epstein-Barr virus-transformed lymphoblastoid cell lines.
Lee DH; Park KS; Kong ID; Kim JW; Han BG
BMC Immunol; 2006 Sep; 7():22. PubMed ID: 16970829
[TBL] [Abstract][Full Text] [Related]
34. Regulation of interleukin-1beta transcription by Epstein-Barr virus involves a number of latent proteins via their interaction with RBP.
Krauer KG; Belzer DK; Liaskou D; Buck M; Cross S; Honjo T; Sculley T
Virology; 1998 Dec; 252(2):418-30. PubMed ID: 9878621
[TBL] [Abstract][Full Text] [Related]
35. The normal cell cycle activation program is exploited during the infection of quiescent B lymphocytes by Epstein-Barr virus.
Hollyoake M; Stühler A; Farrell P; Gordon J; Sinclair A
Cancer Res; 1995 Nov; 55(21):4784-7. PubMed ID: 7585505
[TBL] [Abstract][Full Text] [Related]
36. Lack of BIC and microRNA miR-155 expression in primary cases of Burkitt lymphoma.
Kluiver J; Haralambieva E; de Jong D; Blokzijl T; Jacobs S; Kroesen BJ; Poppema S; van den Berg A
Genes Chromosomes Cancer; 2006 Feb; 45(2):147-53. PubMed ID: 16235244
[TBL] [Abstract][Full Text] [Related]
37. Cell cycle arrest and lytic induction of EBV-transformed B lymphoblastoid cells by a histone deacetylase inhibitor, Trichostatin A.
Seo JS; Cho NY; Kim HR; Tsurumi T; Jang YS; Lee WK; Lee SK
Oncol Rep; 2008 Jan; 19(1):93-8. PubMed ID: 18097580
[TBL] [Abstract][Full Text] [Related]
38. Differential expression of viral and human interleukin-10 (IL-10) by primary B cell tumors and B cell lines.
Stewart JP; Behm FG; Arrand JR; Rooney CM
Virology; 1994 May; 200(2):724-32. PubMed ID: 8178456
[TBL] [Abstract][Full Text] [Related]
39. Accessory function of human leukemic cell lines: properties of B and B-K562 hybrid cell lines.
Wakasugi H; Dokhelar MC; Garson D; Harel-Bellan A; Fradelizi D; Tursz T
Eur J Immunol; 1985 Mar; 15(3):256-61. PubMed ID: 3872216
[TBL] [Abstract][Full Text] [Related]
40. D-type cyclins in adult human testis and testicular cancer: relation to cell type, proliferation, differentiation, and malignancy.
Bartkova J; Rajpert-de Meyts E; Skakkebaek NE; Bartek J
J Pathol; 1999 Apr; 187(5):573-81. PubMed ID: 10398124
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]